Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie L David

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of Clinical Endocrinology and Metabolism|November 2, 2019
Bone Mineral Density Response With Denosumab in Combination With Standard or High-Dose Teriparatide: The DATA-HD RCTSabashini K Ramchand, Natalie L David, Benjamin Z Leder, et al.
The Lancet. Diabetes & Endocrinology|August 27, 2019
Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trialJoy N Tsai, Hang Lee, Natalie L David, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 28, 2021
Efficacy of Zoledronic Acid in Maintaining Areal and Volumetric Bone Density After Combined Denosumab and Teriparatide Administration: DATA-HD Study ExtensionSabashini K Ramchand, Natalie L David, Hang Lee, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 14, 2020
Effects of Combination Denosumab and High-Dose Teriparatide Administration on Bone Microarchitecture and Estimated Strength: The DATA-HD HR-pQCT StudySabashini K Ramchand, Natalie L David, Hang Lee, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2022
The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA-HD Study ExtensionSabashini K Ramchand, Natalie L David, Hang Lee, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 27, 2026
Effects of teriparatide on hip structure and bone microarchitecture in women with anorexia nervosa: a placebo-controlled randomized trialTânia Amorim, Natalie L David, Shria Moturi, et al.
Contemporary Clinical Trials|September 19, 2024
Intermittent fasting for systemic triglyceride metabolic reprogramming (IFAST): Design and methods of a prospective, randomized, controlled trialJacob A Quaytman, Natalie L David, Sharini Venugopal, et al.
JCI Insight|May 23, 2024
Methionine as a regulator of bone remodeling with fastingTânia Amorim, Naveen Gv Kumar, Natalie L David, et al.
JCI Insight|December 10, 2024
Noncoding variation near UBE2E2 orchestrates cardiometabolic pathophenotypes through polygenic effectorsYang Zhang, Natalie L David, Tristan Pesaresi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 23, 2025
Comparative Bone Histomorphometry Effects of Combined Denosumab and Teriparatide versus Monotherapy in Postmenopausal Women with Osteoporosis: A Randomized Controlled TrialSabashini K Ramchand, Joy N Tsai, Yingshe Zhao, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Endocrinology and Metabolism|November 2, 2019
Bone Mineral Density Response With Denosumab in Combination With Standard or High-Dose Teriparatide: The DATA-HD RCTSabashini K Ramchand, Natalie L David, Benjamin Z Leder, et al.
The Lancet. Diabetes & Endocrinology|August 27, 2019
Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trialJoy N Tsai, Hang Lee, Natalie L David, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 28, 2021
Efficacy of Zoledronic Acid in Maintaining Areal and Volumetric Bone Density After Combined Denosumab and Teriparatide Administration: DATA-HD Study ExtensionSabashini K Ramchand, Natalie L David, Hang Lee, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 14, 2020
Effects of Combination Denosumab and High-Dose Teriparatide Administration on Bone Microarchitecture and Estimated Strength: The DATA-HD HR-pQCT StudySabashini K Ramchand, Natalie L David, Hang Lee, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2022
The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA-HD Study ExtensionSabashini K Ramchand, Natalie L David, Hang Lee, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 27, 2026
Effects of teriparatide on hip structure and bone microarchitecture in women with anorexia nervosa: a placebo-controlled randomized trialTânia Amorim, Natalie L David, Shria Moturi, et al.
Contemporary Clinical Trials|September 19, 2024
Intermittent fasting for systemic triglyceride metabolic reprogramming (IFAST): Design and methods of a prospective, randomized, controlled trialJacob A Quaytman, Natalie L David, Sharini Venugopal, et al.
JCI Insight|May 23, 2024
Methionine as a regulator of bone remodeling with fastingTânia Amorim, Naveen Gv Kumar, Natalie L David, et al.
JCI Insight|December 10, 2024
Noncoding variation near UBE2E2 orchestrates cardiometabolic pathophenotypes through polygenic effectorsYang Zhang, Natalie L David, Tristan Pesaresi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 23, 2025
Comparative Bone Histomorphometry Effects of Combined Denosumab and Teriparatide versus Monotherapy in Postmenopausal Women with Osteoporosis: A Randomized Controlled TrialSabashini K Ramchand, Joy N Tsai, Yingshe Zhao, et al.
Pageof 2